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Dedication 
This book is dedicated to the memory of Dr Puggy (Arnold) Hunter, one of Australia's 
outstanding Aboriginal leaders and former Chair of the NationalAboriginal Community 
Controlled Health Organisation, whose vision strongly informed the development and 
revision of this work. Puggy died shortly after reaching his 50th birthday, in September 
2001. His image and his name are used throughout this book in accordance with the 
express wishes of his family. 
Puggy inspired thousands to question and reform Australian efforts to improve 
the health of Aboriginal peoples. He was awarded an Honorary Doctorate in April 
2001 from James Cook University and a posthumous Human Rights Medal for 2001 
from the Human Rights and Equal Opportunity Commission in recognition of his 
exceptional contribution to the advancement of human wellbeing. In 2001, the Puggy 
Hunter Memorial Scholarship Scheme was established by the former Federal Health 
Minister, the Hon. Dr Michael Wooldridge, to support Aboriginal and Torres Strait 
Islander students in their health studies. 
Puggy's moderate voice of influence over the political agenda, his witty intellect and 
moral authority will continue to echo in the hearts of those who knew him.To honour 
Puggy, each chapter is prefaced with his often humorous and always poignant words. 
Foreword 
TO THE FIRST EDITION 
This guide was a culmination of the work of many individuals- Aboriginal and noo-
Aboriginal workers, Aboriginal governing committees-from the Aboriginal Com-
munity Controlled Health Services (ACCHSs) of the Kimberley region of Western 
Australia over the past two decades. The Kimberley ACCHSs, like others around the 
country, arose through a process of Aboriginal community struggle in response to the 
perceived failure of mainstream health services to meet health care needs. 
The achievements of the working partnerships between Aboriginal community 
members. local Aboriginal workers, and non-Aboriginal health professionals with 
technical expertise is an example of the sort of practical grassroots movement for rec-
onciliation being called for by the National Council for Aboriginal Reconciliation.The 
experience of most ACCHSs is that self-determination 'in Aboriginal health care, far 
from conn:i.buting to corrununity division, is a powerful force for community cohesion, 
understanding, and genuine reconciliation between Aboriginal and non-Aboriginal 
Australians. 
like other ACCHSs, we have operated in a climate where the health care needs of 
our people are great and the resources sca rce. It is precisely this type of environment 
which demands a concentration of effo rt on what has been shown to do more good 
than harm and to do so in the most organised way possible. We needed to ensure that 
there was not unnecessary variation in health care practice among members of the 
health care tean), so standardisation of approach became important. Members of the 
health teams required the support of practical problem-based clinical guidelines. These 
considerations led to the development of standard treatment guidelines and systems for 
their application in an Aboriginal primary health care environment. 
The work in development and systematic application of management guidelines 
(ini tially paper-based, then computerised) was initiated by Dr Ian Wronski and Maggie 
Grant in 198B.The guidelines were updated in 1993 by Dr Stuart Garrow and, in 1995, 
Dr Garrow conceived the idea to further develop the guidelines as a resource manual 
for use in the Kimberley. The aims were to explore primary health issues relating to 
important Aboriginal health problems to remove uncertainty in the delivery of preve n-
tive health care, to make service approaches consistent across the IGmberley, to inform 
the implementation of information systems and the use of performance indicators fo r 
quality enhancement, and to promote the integration of health care approaches and 
enhance program sustainability. 
vi 
FOREWORD TO T HE FIRST EDIT I ON vii 
The 'Best Practice Project', as it became known, was possible with the assistance 
of me Commonwealth Department of Health and Family Services, GP Divisions and 
Grants Program. Work on the project commenced in August 1996 with the support of 
the lGmberley Aboriginal Medical Services Council, comprising Aboriginal corrununity 
members representing local health boards across the Kimberley. The development of 
National Health and Medical R esearch Council reconunendations for guidelines, the 
Cochrane Database of Systematic Reviews. the evidence-based medicine paradigm, 
and the National Aboriginal and Torres Strait Islander Health Clearinghouse (Edith 
Cowan University) considerably influenced the format, methodology, and content of 
the review. 
Following discussions with the Office of Aboriginal and Torres Strait Islander Health 
Services during the course of the project, the value of applying the systematic review 
principJes to Aboriginal primary health care issues at a national level was explored. Dr 
Ian Anderson and Ms Alison Dell from the Office worked to develop formal national 
systematic reviews of a range of Aboriginal health issues. The diabetes and ear health 
chapters of this book were expanded for two of these reviews and thus represent 
shortened versions of the Systematic R eviews of Existing Evidence and Primary Care 
Guidelines on the management of diabetes and otitis media in Aboriginal populations 
(which are also currently availabl~). The important role of the Steering Committees 
in the development of these documents is acknowledged. 
This book should help the health staff of ACCHSs, other primary health care 
providers (particularly remote area practitioners), and medical stUdents to understand 
the reasons for interventions and the need for certain approaches to health care tha t 
differ for the Aboriginal population. It should also strengthen the application of'what 
has been shown to do more good than harm', as often there is considerable delay before 
best practice is implemented. 
In Aboriginal health. ~e experienced primary health care practitioner and Abor-
iginal Health Worker will generally have a much better appreciation of the technical 
health care needs of the Aboriginal community than other medical providers. This 
book may help lessen a sense of isolation and empower these practitioners. particularly 
those working in remote areas, to feel confident dealing with health problems about 
which they may have had little formal training and for which information may be 
poorly accessible. Hopefully, this book will help to disseminate the valuable research 
and experience that health professionals working with Aboriginal people have acquired· 
over many years. 
Finally, I hope that this work will have a real impact on the health of my people 
from the Kimberley, and Aboriginal people across the country who bear so great a 
burden of sickness and grief. 
Puggy Hunter 
CHAIRPERSON 
NATIONAL ABOR IGINAL COMMUNITY CONTROllED HEALTH ORGANISATION (NACCH O) 
ANO KIMBERLEY ABORIGINAL MEOICAL SERVICES COUNCI L (KAMSC) 
MAY t 998 
Foreword 
TO THE SECOND EDITION 
Following the success ofche first edition of this book, the Kimberley Aboriginal Medical 
Services Council is pleased to endorse this second edition, developed with the assistance 
of Dr Sophie Couzos and D r Richard Murray. This edition includes many additional 
chapters as well as revisions to the current chapters. 
I am confident that this book will be tter equip health professionals with the infor-
mation and knowledge needed for best practice in the delivery of primary health care to 
Aboriginal communities and help achieve the healthy outcomes we are all seeking. 
The book is a techn ical resource, to assist you in dealing with some of the more 
common obstacles and (ash that you may face every day when working in Aboriginal 
health. It shows what we know works, in a best-practice and culturally safe way, and 
can be used in the clinic, home, or school context. r am prou'd of this book, which has 
been entirely developed, produced, and published to improve the delivery of health 
care to Aboriginal people. 
Aboriginal health has been ignored or suppressed in the health system for too long 
now. In rece nt years, however, thinki ng has started to change. Aboriginal health is now 
taught at various levels in many educational training centres around Australia,and there 
is marc interest than ever among health professionals who want to understand how 
to deal with health problems and the process of delivering heal th care to Aboriginal 
people. 
I would recommend that aU health professionals and others involved in the design 
and del ivery of primary health care services to Aboriginal communities become familiar 
with this book. It provides key tools for ensuring aU health professionals meet the needs 
of our culturally and linguistically diverse society. 
Lastiy, I am honoured to acknowledge Dr Arnold Puggy Hunter fo r his life-time 
contribution in ensuring Abor iginal people have access to the best possible health 
care. 
viii 
YOURS IN HEALTH, 
Henry Councillor 
CHIEF EXECUTIVE OFFICER 
KIMBERLEY ABORIGINAL MEOICAL SERVICES COUNCIL INC. 
SEPTEMBER 2003 
Foreword 
TO THE THIRD EDITION 
Following the success of the firs t and second editions oEtms book, the Kimberley Abor-
iginal M edical Services Council is pleased to release a third edition. We are grateful to 
the editors and authors Dr Sophie Couzos and Associate Professor Richard Murray as 
well as many other contributing authors who are widely respected in their field . 
This landmark text includes several new chapters on antenatal care, respiratory 
infection (including bronchiectasis), and asthma, as well as extensive revisions of every 
chapter.Thc book is a crucial resource for health care providers in prevention, diagnosis, 
and effective treatment of health problems among Aboriginal populations. It will help 
support best practice, not just in clinical care, but in broader aspects of policy and the 
historical, cultural, and social dimensions of Aboriginal primary health care. 
A strength of the book is that it is based on best evidence as well as the realities of 
Aboriginal health care as informed by health professionals with extensive experience 
working in the fidel. Many publications and reports claim to promote best prac-
tice, but lack grounding in the comple>ci tics and diversity of Aboriginal community 
experience. 
Our aim is to enhance the personal and profess ional competence of all health carc 
providers in working with Aboriginal communities to ensure that practice is both 
culturally appropriate and technically effective. I strongly recommend that all health 
care providers and anyone involved in the design and delivery of primary health care 
services to Aboriginal communities become familiar with this book. 
YOURS IN HEALTH, 
Henry Councillor 
CHIEF EXECUTIVE OFFICER 
KIMBERLEY ABORIGINAL MEDICAL SERVICES COUNCil INC. 
CHAIRPERSON 
NATIONAL ABORIGINAL COMMUNITY CONTROllED HEALTH OR GANISATION 
NOVEMBER 2007 
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Introduction 
Please. before YOII go rI//lning off witli all good illtEIIliolU, talk to Ollr 
11100 arotlHd the COlll1ill1, Talk to our services, because [ can flollestly tell 
)lol/from rIfe positiolllhal NACCHO is ill, we would 110(-1 will 
not- C!lIdorse aJ1J'thing that comes (0 Ihe table thaI ham't been endorsed 
by 1lI}1 loml COllll1l1ll1ity or throllgh the State vodies. So if you are going 
to do Aborigil1al healtll, do it witli I/S/ don't do it wit/zollt us. 
Th. late Dr Puggy Hunler 
This book is a guide to help health professionals deliver primary health care and 
develop health policy that is appropriate, valid, sustainable, and acceptable to Aboriginal 
populations. 
It is a reference document from which students, health providers, and organisations 
can access summarised 'evidence' relating to health problems faced by Aboriginal peoples 
and Torres Strait Islanders, but it also serves to guide clinical practice through explicit 
supported statements that help practitioners make decisions in the clinical situation I 
While the book may be seen as a guideline in this respect, its role is more as a resomce 
for the local development of guidelines or a template against which to achieve local 
agreement so as to enhance the implementation of best practice. The local development 
or modification of guidelines by general practitioners/health staff who will be using 
them is a well-recognised and critical strategy to facilitate implementation is thought 
to be an important strategy in general practice.2•J,4 
This book is also a tool for enabling more equitable health system responsiveness 
to the Aboriginal and Torres Strait Isl:inder population. There is a strong health policy 
and population approach that informs on disparities in access to health care and where 
reforms are needed. It is hoped the book will help to overcome bureaucratic inertia 
by providing evidence for preventive interventions and health policies that can make 
a difference. 
Primary health care 
The delivery of health care to Aboriginal and Torres Strait Islander populations invariably 
has a strong disease-control or public health focus because of the continuing burden of 
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diseases associated with poverty. An emphasis on both the individual and the population 
is a hallmark of primary health care. 
The Aboriginal Community Controlled Health Services (ACCHSs) have been 
implementing primary health care since the early 1970s, wben they were first devel-
oped.The international movement to implement health care that encompassed health 
promotion strategies, nutritional and environn~ental interventions for disease control, 
social supports, and essential drugs in addition to primary medical care was defmed 
as 'primary health care' by the World Health Organization (WHO) Conference in 
Alma-Ata in 1978.' 
Aboriginal Community Controlled Health Services still best exemplify the delivery 
of primary health care in Australia.'Primary health care' according to the National Abor-
iginal Community Controlled Health Organisation (NACCHO) is defined as essential, 
integrated care based upon scientifically sound and socially acceptable procedures and 
technology made accessible to conununities (as close as possible to where they live) 
through their full participation, in the spirit of self-reliance and self-determination. 
Subject to the availability of resources, care involves the treatment of diseases and 
management of chronic disease, provision of medication, preventive medicine, dental 
health, counselling, health education and promotion, rehabilitative services, antenatal 
and postnatal care, maternal and child care, and environmental health and community 
support services (such as transport, advocacy, hOl1le care, interpreting services, school 
health, prison health, funeral support, provision of food, financial assistance, etc) in a 
holistic context· 
Primary health practitioners are patient advocates and have a fundamental role to 
play in ensuring health equity. This means that the social and economic forces that 
influence health and disadvantage patients are considered in the provision of health care. 
The breadth of preventive interventions, together with their indisputable importance, 
is what makes primary health care so vital yet so misunderstood by policy makers as 
evidenced by insufficient resourcing of the sector that targets the Aboriginal andTorres 
Strait Islander population (chapters 1 and 2). 
Evidence-based practice 
The health care paradigm of evidence-based practice has focused attention on the 
determinants of current practice and the need for 'best practice' in the management 
of important health problems! Evidence not only drives clinical interventions, but 
should also drive policy,' although this is rarely the case (chapter 2). Health providers are 
now very aware of the value of evidence-based approaches that aim to improve health 
outcomes by focusing on health care processes that have been shown to: do more good 
than harD1, decrease practice variation, and optinlise resource utilisation.1} 
Practice variation often sten~s [1'0111 uncertainty in the types of interventions that 
work best, especially for the health problems faced by the Aboriginal and Torres Strait 
Islander population. This is because of Aboriginal people's greater burden of disease: 
higher levels of co-existing morbidity; poorer access to health systems, education, and 
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health hardware; and preponderance of diseases reflecting poverty and disadvantage 
that are uncommon in other Australians such as skin infections, suppurative ear infec-
tions, trachoma, tuberculosis, and rheumatic fever. Some diseases considered to have 
been eradicated from Australia still occur in the Aboriginal and Torres Strait Islander 
population (for example,leprosy). 
Many students also receive no training in handling these matters. In ACCHSs 
where nearly 90% of the episodes of care are to Aboriginal or Torres Strait l slandel~ 
patients, '0 there is a frequent turnover of health staff, and a great deal of practice is based 
on 'word of mouth' passed on through an apprenticeship system or by trial and error 
repeated over the years.Valuable time and goodwill may be lost in the process and this 
is compounded by the difficulties in doctor recruitment for ACCHSs across Australia, 
so a need for guidance on the delivery of evidence-based preventive interventions is 
fundamental. The good news is that in 2004 the Committee of Deans of Australian 
Medical Schools (now known as Medical Deans Australia) endorsed a national curri-
culum framework for the inclusion of the health of Aboriginal peoples and Torres Strait 
Islanders in all medical curricula." 
How health policy in Australia is made (or not made) is also generally a mystery 
to those who deliver clinical care. This need not be the Case and is largely the result of 
medical curricula lacking content on the Australian health policy process. Knowledge of 
health policy is of vital importance when delivering health care to Aboriginal peoples 
because the health sector perpetuates inequities when it excludes those who need 
health care the most. How this happens should be understood, lest health professionals 
unwittingly contribute to these inequities. 
Terminology 
... they even tried to can us some SOL"[ of insect a while ago by c<llling us 'A[Sics' and 
now they still try to chuck us together in a sense by saying 'indigenous'. 
Or Puggy Hunter, 
Opening Address, 6th National Rural Health Conference, March 2001 
This book respects the preferred terminology when referring to the Aboriginal and 
Torres Strait Islander population. 12 The term 'Aboriginal peoples' reflects the diversity 
of the original people of Australia. The term 'Indigenous Australians' is less commonly 
used .• md Indigenous is always capitalised. 
Although this book makes reference to Aboriginal people's health, there is signif-
icant heterogeneity within this population, with diverse Aboriginal nations each with 
their own language and traditions. I.} Aboriginal peoples in different regions of Australia 
f.,ce similar but at times different health problems, or the same health problems but to 
dit1"rent degrees. Moreover. the health of Torres Strait Islanders, who come trom the 
islands of the Torres Strait beyond Cape York in Queensland, is very similar to that 
of Aboriginal peoples butTorres Strait Islanders represent a distinct Indigenous Aust-
ralian popui:ltion. While atlthors of this book have taken care to distinguish between 
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populations, many studies combine Aboriginal and Torres Strait Islander population 
data, and therefore effort has been made to be inclusive so that the information in the 
book can be applicable to both Aboriginal peoples and Torres Strait Islanders. 
Generalisability 
In Australia, interventional research involving the Aboriginal Or Torres Strait Islander 
population is rare. Consequently, for this book there was a need to draw on international 
studies and expert consensus statements that could be generalised to the Aboriginal 
and Torres Strait Islander population. 
The 'transferabilicy' or 'generalisabilicy' of research is the inference that research 
findings in one population can be applied to others. One way of defining populations 
is by their't-ace' / ethnicity, but generalising research is usually more about characterising 
the influence offactors other than 'race' I ethnicicy per se on expected outcomes. Some 
of the factors which may influence the generalisability of research are differences in 
age, sex, degrees of biomedical risk, diagnostic skill of practitioners, health resources, 
client adherence, and socioeconomic status ." In applying research findings to other 
populations, the question may be posed: 'Is my patient so different from those in the 
trial that its results cannot help me make my treatment decision?"s 
Using ethnicicy to justify against generalising research findings can be potentially 
unethical. For example, there is little evidence that ethnicicy predicts differences in 
pharmacological responsiveness because it cannot be given a precise biological defin-
ition as race and ethnicity are widely agreed to be social constructs. 1(,,17 Using ethnicity 
as a criterion may inappropriately deny medicines to certain population groups when 
they have been shown to work generally." 
Policy makers are tending to place emphasis on commissioning research that examines 
whether treatments or health systems applied to IndigenousAustralian populations and 
health care settings achieve the same outcomes as those already shown for the general 
population. The reasons for this may be political, or may be due to misunderstanding.'· 
One thing is certain: given the significant heterogeneity of the Aboriginal and Torres 
Strait Islander population within Australia, it is not possible to make any generalisation 
about an ethnographic basis for differences ill therapeutic outcomes. 
A famous example of the exploitation of the characteristics of trial subjects was 
the US Food and Drug Administration (FDA) approval of the isosorbide/hydralazine 
drug combillation for heart failure'o for only one etlmic/racial group (African Amer-
icans).The evidence from the trial did not show variations in drug response attributed 
to ethnic group, it merely showed it worked in African Americans. The regulatory 
restrictions on ethnicity were . imposed only because they were requested by the 
drug company" for market gain. The FDA's defence was that making the medicine 
available was in the interests of African Americans." While others believe this was 
well intentioned, it was a Rawed interpretation of the trial and set back future drug 
approval mechanisms." There is a difference between policy that allocates medici"," 
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to population subgroups because of disparate disease burdens from tbat which suggests 
ethnic differences in efficacy. 
The issue of generalising study findings is now being investigated at the genetic level. 
Pharmacogenomics is a new field exploring the genetic basis for differences in drug 
responses with the aim of predicting individual responsiveness to therapy," but it raises 
ethical and legal concerns if applied inappropriately to population subgroups.25.2(, 
Many individual and population-based interventions do not involve drug therapy 
and the generalisabiliry of external studies in these situations may be dependant on 
Aboriginal people's values. culture, social expectations, expertise in progrml1 delivery, 
and resources. This explains the need for Indigenous-specific programs and policies, 
in addition to the equiry argument. Such considerations should not be used to deny 
services or policies directed to the Aboriginal and Torres Strait Islander population. 
The key message regarding generalisabiliry is that too much emphasis is placed on 
whether research findings apply to a certain patient population. The complaint has 
been: 'but no study has shown that this works in the Aboriginal population'; when, 
in f.,ct, 'energy currently devoted to agonising over the minutiae of the inclusion and 
exclusion criteria used to generate tlle research evidence, is better spent considering 
how it can be applied to the special situations and values of our patients' 27 
Format of the book 
All of the health problems reviewed in this book contribute significantly to the burden 
of disease affecting Aboriginal peoples, but are amenable to prevention and to improve-
ments in the consistency of practice (by reducing unnecessary variations), with me 
potential to reduce morbidiry and costs to the health sector if interventions are widely 
implemented. The 3rd Edition Reference Group (see Acknowledgments) guided the 
process of revision and the selection of new chapters. Selected authors represent those 
invited by the Reference Group on the basis of their expertise in the subject matter. 
All chapters, with the exception of those addressing the policy process, social issues, 
org<lI1ised prevention, well person's health check, and pregnancy care have a similar 
format. They begin with health policy positions endorsed by governments or other 
bodies, which may describe health goals and targets for the Aboriginal and Torres Strait 
Islander population. Identifying such agreements (or lack thereof) is of vital impor-
tallce as health policies set the scene for primary health care resourcing, and can thus 
inAuence clinical care.The absence of an agreement or policy may assist in opening up 
opportunities for their development. To understand the importance of health policy, 
till' editors strongly encourage reading chapters 1 and 2 of this book. 
Ch,rpt"r sections on the burden of disease, case definitions, and diagnostic procedures 
til II O\\" 'goals and targets', with subsequent discussion of the evidence for preventabiliry. 
In lll"lkr to define, organise, and separate prevention strategies from standard disease 
11l:'.llagl'Il1C'IH approaches, 'prevention' has been divided into priu1ary, secondary, and 
[l'niary types: 
xlvjii INTROOUCTION 
primary prevention-aims at complete avoidance of the disease or to delay its 
onset 
secondary prevl!ntion-aillls at detecting and curing tht:' disease before it causes 
symptoms 
tertiary prevention- aims at minimising the consequences for a patient who already 
has the disease. 
T hese definitions reflect the public or population health approach to disease con-
trol. 2:-1 This approach was selected in order to enable syslewtlli{ disease l11anagenlent 
because this is what defines prilllM)' IIen ltil enre and ditTerentiates it from primary medical 
care. hospital care. or palliative Care. Primary health care practitioners need to view the 
management of disease at alilevels-frol1l interventions that influence health hardware. 
social or behavioural factors. or the provision of immunisation or chemoprophylaxis 
before the disease is evident. through to interventions that engage with tertiary level 
health care and rehabilitation services. 
Methodology 
Because of the breadth of the subjects addressed in this book. many types of evidence 
were used. The use of primar), research has been cOlnbined with existing i"tegrative SUJII· 
maries sllch as systenutic reviews and nle ta-analyses and, w hen unavailable, the usc of 
overviews or narrative summaries by experts. Clilliwi practice gllidelines developed and 
used by other health services. nationally and internationally. have been used in order 
to address practical issues for which evidence was lacking. such as optimal follow-up 
periods after treatment. 
The collation and synthesis of research in a systematic review considers the hierarchy 
of primary research . The best 'evidence' that defines optimal therapeutic approaches 
is tbat derived from randomised controlled trials. A combination of randomised con-
trolled trials synthesised in a meta-analysis or systematic review constitutes evidence 
of the highest quality because it is least subject to bias2 "The following sys tem ofleveis 
of research evidence illustrates tbis hierarchy: 
level I-based on studies. such as meta-analysis or systematic reviews. of all relevant 
randol11ised co ntrolled trials 
level II-based on well-designed randomised controlled trials 
level Ill- based on well-designed cohort or case-control analytic studies 
level IV-based on opinions of respected authorities, clinical experience. descriptive 
studies , and case reports or reports of expert COlllI11ittees. 
In order to supplement areaS of clinical uncertainty, authors have sourced evidence 
that comprised expert opinion through position statements, guidelines, and other 
consensus-based documents. The use of grey literature (unpublished) and published 
Aboriginal expert opil1ion (for example. Aboriginal H ealtb Workers) was encouraged. I' 
is important to acknowledge that clinical decisions still bave to be made in the absence 
of research evidence. which highlights the importance of expert opinion as reported 
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fi-om consensus statements or overviews. This book has used expert opinion where 
there is an absence of higher-level evidence. 
Authors used a qualitative approach to synthesis of the research literature sin1ilar to 
that used by the US Preventive Services Task Force.'" Integration took the form of a 
narrative summary within chapters. Other forms of synthesis included tabular represen-
tation of studies and their major findings. 
Implementation 
Although individual health services should decide how they will 'put prevention into 
practice', clinical chapters have a section on implementation, data collection, and 
performance indicators to provide a practical framework. In order for guidelines to 
become part of the routine primary care process, this book has suggested care plans 
and recall schedules where relevant as well as general principles for organising preven-
tion (chapter 4).These can assist services to measure progress and are a part of quality 
assurance activity that is increasingly being requested of services by funding bodies. 
S0111e perforInance indicators or process indicators have been suggested, the collec-
tion of which will depend on the sophistication of the information technology used 
by services. Ultin1ately, the collection, aggregation, and analysis of this practice level 
inforlllation is a n1atter for individual health services to deterInine. 
The en1phasis on population approaches is crucial in infonning services on how 
to optimise field team and opportunistic preventive health care delivery, as well as 
assisting regional public health units with progral11 design. The recon1111endations are 
not intended to be prescriptive. Standard treatment manuals are widely available and 
should be consulted.'1.32 
Guidelines for clinical practice are useless if they are not used. It is hoped that this 
book will strengthen the substantial contribution that Aboriginal and non-Aboriginal 
primary health care providers such as general practitioners, nurses, Aboriginal Health 
Workers, allied health workers, and students are making in their efforts to make the 
health system more equitable for Aboriginal peoples and Torres Strait Islanders across 
Australia. If we were to see an authentic political COn1111itinent towards 'health equality 
within a generation' for Aboriginal peoples in the next few years," we could also hope 
that by :wn a book such as this would not be needed. 
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